When preparing your application, note that references are now explicitly excluded from the 15-page proposal limit. Pfizer has also clarified that your budget may include indirect costs alongside direct costs and the 28% overhead cap. Finally, if you need to email the grant officer with questions, be sure to use the newly specified subject line "2026 I&I US JAKi Rheum IME".
Funder: Pfizer Inc.
Due Dates: May 21, 2026 (Submission Deadline, full application — due by 23:59 EST)
Funding Amounts: Up to $100,000 per project; project duration up to 12 months; total budget for this RFP is $100,000.
Summary: Supports independent medical education projects to advance healthcare professionals' understanding and evidence-based use of generic JAK inhibitors in rheumatologic disease management.
Key Information: Late applications will not be reviewed; only organizations (not individuals) are eligible.